The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia.
about
A leading role for the immune system in the pathophysiology of preeclampsiaAngiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyondTelmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathwayExcess LIGHT contributes to placental impairment, increased secretion of vasoactive factors, hypertension, and proteinuria in preeclampsia.The placenta: transcriptional, epigenetic, and physiological integration during developmentRole of biomarkers in early detection of preeclampsiaAutoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia.Targeted expression of Cre recombinase provokes placental-specific DNA recombination in transgenic mice.Disrupted balance of angiogenic and antiangiogenic signalings in preeclampsia.A2B adenosine receptor-mediated induction of IL-6 promotes CKD.Maternal treatment with agonistic autoantibodies against type-1 angiotensin II receptor in late pregnancy increases apoptosis of myocardial cells and myocardial susceptibility to ischemia-reperfusion injury in offspring rats.The relevance of the Renin-Angiotensin system in the development of drugs to combat preeclampsia.Recombinant vascular endothelial growth factor 121 attenuates autoantibody-induced features of pre-eclampsia in pregnant mice.Receptor-activating autoantibodies and disease: preeclampsia and beyond.Autoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia.Renin angiotensin signaling in normal pregnancy and preeclampsia.Angiotensin II revisited: new roles in inflammation, immunology and aging.Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling.Soluble fms-like tyrosine kinase 1 promotes angiotensin II sensitivity in preeclampsia.Transglutaminase is a Critical Link Between Inflammation and Hypertension.Characterization of antibody specificities associated with preeclampsiaAnimal models of pre-eclampsia.The pathophysiology of preeclampsia involves altered levels of angiogenic factors promoted by hypoxia and autoantibody-mediated mechanisms.Activating autoantibodies and cardiovascular disease.A complicated role for the renin-angiotensin system during pregnancy: highlighting the importance of drug discovery.Linking the old and new -- do angiotensin II type 1 receptor antibodies provide the missing link in the pathophysiology of preeclampsia?Preeclampsia As Modulator of Offspring Health.Angiotensin II type 1 receptor antibodies in childhood kidney transplantation.Recent Advances in Immunity and Hypertension.The effects of Nrf2 deletion on placental morphology and exchange capacity in the mouse.Angiotensin type 1 receptor autoantibody from preeclamptic patients induces human fetoplacental vasoconstriction.Maternal-Fetal rejection reactions are unconstrained in preeclamptic women.Vitamin D supplementation reduces some AT1-AA-induced downstream targets implicated in preeclampsia including hypertension.
P2860
Q27003069-D9A2E088-06C7-4BFB-917C-86859414AAF4Q27027039-E42F3479-F239-45CB-B220-0BD3DD0F324DQ33672325-A27A5714-A898-43CC-9E74-C7D388E8BDCEQ33740993-9547C543-20B4-4C41-A82D-43617C98F5CCQ33755392-0B7D01F7-F602-4A92-A8AC-53D380C23F7FQ33783531-CBECF952-AF50-4688-91D7-BE9D34C44696Q34040357-CF24E835-4949-4CA9-964E-DDD10D8ACA68Q34169819-49E68E6A-3039-40E5-8736-3F6ACB3ED2FBQ34731047-1EE9CDF6-6B52-4CE0-9FA9-EC2C7BCF7D95Q34870775-FE74E48A-302D-495F-9AB2-CD8C1740A747Q35053657-DDE51D88-401F-4A7C-BAA5-9EAF8814A431Q35591704-71A08C76-7C71-4576-921A-A15E3F58E9CBQ35683468-42252CEF-3F19-42BC-BF39-F4D78AFD8A73Q35707881-57ED5D36-81BF-4144-8F27-CE9D2CD4D837Q35715914-839FD387-0AFA-444D-8910-86DB714F1F1AQ35743816-05288DED-CABD-46A7-B0AC-C8D326904AEDQ36039299-B5AC66D8-A561-41B8-8325-A51AA8620E7EQ36050771-B26D9924-85EA-4AE8-A416-BFD157BD9B90Q37042332-5692FC3F-563D-441C-84D2-2EE132B70978Q37240779-3C7418DF-7E87-4A28-A349-C0B476C42649Q37699015-2687DEA9-E2F6-4903-856D-568FBF8DA05AQ37816496-AD339344-7399-46A4-8724-8D87542FE213Q38014802-64183020-4081-4241-8DBA-55FCC5A85AEDQ38118625-6FF1E4E6-2B60-4F28-A0BA-84C30627E5DDQ38126570-4F5954BD-BDDF-4337-8B22-ADFB89E89BA4Q38543831-D7884D04-8C95-45C5-A46C-FAA8C7456F3BQ38705264-9D80C859-2F38-438D-96D2-40A011EFEAFEQ38859507-B882223B-CDB5-40BA-B5B9-9F23E379B83CQ39136791-56A46D59-4D25-404C-A30A-EDBE7FDBDE12Q39385098-04CF1AA3-46F3-4F45-BDBD-BBAD60EC7E05Q43939628-A4673380-D8EA-4EAA-84A9-929AFEB9552FQ46212939-4546B3BB-6486-4579-A5CF-FEDDE7BB96E6Q51294484-76A3DAF1-53B9-45A5-8DC9-D5EFE6F7D6C8
P2860
The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The detrimental role of angiot ...... triction seen in preeclampsia.
@ast
The detrimental role of angiot ...... triction seen in preeclampsia.
@en
type
label
The detrimental role of angiot ...... triction seen in preeclampsia.
@ast
The detrimental role of angiot ...... triction seen in preeclampsia.
@en
prefLabel
The detrimental role of angiot ...... triction seen in preeclampsia.
@ast
The detrimental role of angiot ...... triction seen in preeclampsia.
@en
P2093
P2860
P356
P1476
The detrimental role of angiot ...... triction seen in preeclampsia.
@en
P2093
Cissy Chenyi Zhou
Rodney E Kellems
Roxanna A Irani
Sean C Blackwell
Susan M Ramin
Yujin Zhang
P2860
P304
P356
10.1084/JEM.20090872
P407
P577
2009-11-02T00:00:00Z